Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,801,865
-$1,149,850 QoQ
Shares Held
100,215
-20.5% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0%
Shared 71%
None 29%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,419,413,768 across 180 Biotechnology names. URGN ranks #117 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in URGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,801,865 | 100,215 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,951,715 | 126,034 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,499,694 | 125,298 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,165,311 | 158,052 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,637,741 | 148,078 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,565,049 | 146,953 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,743,709 | 137,300 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,618,987 | 156,078 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,051,115 | 136,741 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,569,000 | 104,600 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $981,582 | 70,063 | Shares | Defined | 2023-11-14 | |
| 2021-12-31 | $2,263,455 | 238,008 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,336,986 | 317,300 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $21,219,571 | 1,389,625 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $32,231,275 | 1,654,583 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $33,168,276 | 1,840,637 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $38,502,644 | 1,995,990 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $52,281,579 | 2,001,592 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $19,541,666 | 1,095,385 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||